Finanzwire Finanzwire
Basculer en Français
10230 Companies
211162 Keywords
141077 Articles
111858 Press releases
Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG Remove
  1. Home
  2. Companies
  3. Secarna Pharmaceuticals GmbH & Co. KG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/03/2023 at 18:05, 2 years 5 months ago

    Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/25/2023 at 15:00, 2 years 5 months ago

    Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/17/2023 at 14:00, 2 years 5 months ago

    Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 07/06/2023 at 14:00, 2 years 9 months ago

    Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 06/05/2023 at 14:00, 2 years 10 months ago

    Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 03/27/2023 at 16:04, 3 years ago

    Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
Previous page
1 ... 3 4
Accesswire
  • Published on 04/17/2026 at 02:13, 4 hours 42 minutes ago

    CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle

  • Published on 04/17/2026 at 02:00, 4 hours 55 minutes ago

    UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement

  • Published on 04/16/2026 at 23:32, 7 hours 23 minutes ago

    Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale

  • Published on 04/16/2026 at 21:30, 9 hours 25 minutes ago

    Organto Foods Expands Financing Facilities with Rabobank

  • Published on 04/16/2026 at 15:55, 15 hours ago

    TripSitter Announces Director Resignation

View all ACCESSWIRE
EQS Group
  • Published on 04/17/2026 at 04:55, 1 hour 59 minutes ago

    Hyundai Mobis Develops Data-Driven Validation System to Dramatically Cut Testing Time for SDVs

  • Published on 04/16/2026 at 23:40, 7 hours 14 minutes ago

    Coventry Ranks #1 in 2025 Life Settlement League Table Report

  • Published on 04/16/2026 at 21:37, 9 hours 17 minutes ago

    Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.

  • Published on 04/16/2026 at 21:00, 9 hours 54 minutes ago

    Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment

  • Published on 04/16/2026 at 20:35, 10 hours 19 minutes ago

    EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year

View all EQS
Les Echos
  • Published on 04/16/2026 at 18:02, 12 hours 53 minutes ago

    Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026

  • Published on 04/16/2026 at 18:00, 12 hours 55 minutes ago

    ICADE – PR – Q1 2026 TRADING UPDATE

  • Published on 04/16/2026 at 17:55, 12 hours 59 minutes ago

    Publication of 2026 1st quarter turnover

  • Published on 04/16/2026 at 17:54, 13 hours 1 minute ago

    Aéroports de Paris S.A - March 2026 traffic figures

  • Published on 04/16/2026 at 17:45, 13 hours 10 minutes ago

    VOGO : 2025 full-year results.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy